Neoeriocitrin (Standard)

Overview

Neoeriocitrin (Standard) is the analytical standard of Neoeriocitrin ( HY-N4119 ). This product is intended for research and analytical applications. Neoeriocitrin is a Naringin ( HY-N0153 ) analogue found in Drynaria Rhizome. Neoeriocitrin induces cells proliferation, differentiation, up-regulates type I collagen , osteocalcin, and key osteogenic markers, and increases ALP activity. Neoeriocitrin increases expression of Runx2 , COL I, OCN and Beclin1 . Neoeriocitrin inhibits phosphorylation of P38 mitogen-activated protein kinase , reduces acetylcholinesterase ( AChE ) activity, and increases choline acetyltransferase ( ChAT ) activity. Neoeriocitrin reduces apoptosis and induces autophagy . Neoeriocitrin can be used for the researches of osteoporosis and Alzheimer's disease.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Others | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > MAPK/ERK Pathway | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Autophagy | Products > Research Areas > Neurological Disease | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Cholinesterase (ChE) | Products > Signaling Pathways > p38 MAPK | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Autophagy | Products > Signaling Pathways > Reference Standards | Products > Signaling Pathways > Phosphatase

Product Information

• Catalog No.: HY-N4119R
• CAS No.: 13241-32-2
• Molecular Formula: C27H32O15
• Molecular Weight: 596.53
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source